Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.000
+0.070 (2.39%)
Dec 20, 2024, 4:00 PM EST - Market closed
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 124 employees as of December 31, 2023. The number of employees decreased by 32 or -20.51% compared to the previous year.
Employees
124
Change (1Y)
-32
Growth (1Y)
-20.51%
Revenue / Employee
$327,097
Profits / Employee
-$1,445,839
Market Cap
213.80M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 124 | -32 | -20.51% |
Dec 31, 2022 | 156 | -21 | -11.86% |
Dec 31, 2021 | 177 | 53 | 42.74% |
Dec 31, 2020 | 124 | 62 | 100.00% |
Dec 31, 2019 | 62 | - | - |
Related Stocks
Company Name | Employees |
---|---|
SOPHiA GENETICS | 430 |
ADC Therapeutics | 274 |
LifeMD | 211 |
Precigen | 202 |
biote | 194 |
Utah Medical Products | 190 |
Acrivon Therapeutics | 61 |
DiaMedica Therapeutics | 19 |
ZNTL News
- 9 days ago - Zentalis Pharmaceuticals Announces Key Management Appointments - GlobeNewsWire
- 19 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewsWire
- 2 months ago - FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc - GuruFocus
- 3 months ago - FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers - Benzinga
- 3 months ago - Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies - GlobeNewsWire
- 3 months ago - Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024 - GlobeNewsWire
- 4 months ago - Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL - Business Wire